Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 59, Issue 3, 2005, Pages 491-500

  Teixeira, Maribel ^a,b   Alonso, Maria J ^c   Pinto, Madalena M M ^a   Barbosa, Carlos M ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b Inst Sup de Ciencias da Saude N   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d CETMED Centro Tecn do Medicamento   (Portugal)

Author keywords

3 Methoxyxanthone; Nanocapsules; Nanoparticles; Nanospheres; PLGA; Xanthone

Indexed keywords

3 METHOXYXANTHONE; NANOCAPSULE; NANOPARTICLE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; PARTICLE SIZE; PARTITION COEFFICIENT; THERMAL ANALYSIS; ZETA POTENTIAL;

EID: 14844303762     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.09.002     Document Type: Article

References (45)

1. V. Peres, T.J. Nagem, and F.F. de Oliveira Tetraoxygenated naturally occurring xanthones Phytochemistry 55 2000 683 710
2. M.M.M. Pinto, and E.P. Sousa Natural and synthetic xanthonolignoids: chemistry and biological activities Curr. Med. Chem. 10 2003 1 12
3. C.N. Lin, M.I. Chung, S.J. Liou, T.H. Lee, and J.P. Wang Synthesis and anti-inflammatory effects of xanthone derivatives J. Pharm. Pharmacol. 48 1996 532 538
4. E.R. Fernandes, F.D. Carvalho, F.G. Remião, M.L. Bastos, M. Pinto, and O.R. Gottlieb Hepatoprotective activity of xanthones and xanthonolignoids against tert-butylhydroperoxide-induced toxicity in isolated rat hepatocytescomparision with silybin Pharm. Res. 12 1995 1756 1760
5. M. Pinto, and M.S.J. Nascimento Anticomplementary activity of hydroxy- and methoxyxanthones Pharm. Pharmacol. Lett. 7 1997 125 127
6. M.J. Gonzalez, M.S.J. Nascimento, H. Cidade, M.M. Pinto, A. Kijjoa, C. Anantachoke, A.M. Silva, and W. Herz Immunomodulatory activity of xanthones from Calophyllum teysmannii var. inuphylloide Planta Médica 65 1999 368 371
7. M. Pedro, F. Cerqueira, M.E. Sousa, M.S.J. Nascimento, and M. Pinto Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human limphocytes in vitro Bioorg. Med. Chem. 10 2002 3725 3730
8. L. Saraiva, P. Fresco, E. Pinto, E. Sousa, M. Pinto, and J. Gonçalves Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives Bioorg. Med. Chem. 10 2002 3219 3277
9. L. Saraiva, P. Fresco, E. Pinto, E. Sousa, M. Pinto, and J. Gonçalves Inhibition of α, βI, δ and ζ protein kinase C isoforms by xanthonolignoids J. Enzym. Inhib. Med. Chem. 18 2003 357 370
10. A. Sanches, J.L. Vila-Jato, and M.J. Alonso Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporine A Int. J. Pharm. 99 1993 263 273
11. Y.I. Kim, L. Fluckiger, M. Hoffman, I. Lartaud-Idjouadiene, J. Atkinson, and P. Maincent The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats Br. J. Pharmacol. 120 1997 399 404
12. C. Fonseca, S. Simões, and R. Gaspar Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity J. Control Release 83 2002 273 286
13. M.J. Alonso Nanoparticulate drug carrier technology S. Cohen H. Bernstain Microparticulate Systems for the Delivery of Proteins and Vaccines 1996 Marcel Dekker New York 203 242
14. P. Couvreur, C. Dubernet, and F. Puisieux Controlled drug delivery with nanoparticles: current possibilities and future trends Eur. J. Biopharm. 41 1995 2 13
15. P.J. Lowe, and C.S. Temple Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats J. Pharm. Pharmacol. 46 1994 547 552
16. P. Couvreur, E. Fattal, H. Alphandary, F. Puisieux, and A. Andremont Intracellular targeting of antibiotics by means of biodegradable nanoparticles J. Control Release 19 1992 259 268
17. R. Jain, N.H. Shah, A.W. Malick, and C. Rhodes Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches Drug Dev. Ind. Pharm. 24 1998 703 727
18. H. Fessi, J.P. Devissaguet, F. Puisieux, C. Thies, Procédé de préparation de systèmes colloidaux dispersibles d'une substance sous forme de nanoparticules, French Patent, 2,608,988 (1988).
19. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4
20. P. Legrand, G. Barratt, V. Mosqueira, H. Fessi, and J.P. Devissaguet Polymeric nanocapsules as drug delivery systems. A review STP Pharma Sci. 9 1999 411 418
21. V.C.F. Mosqueira, P. Legrand, H. Pinto-Aphandary, F. Puisieux, and G. Barrat Poly(d,l-Lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on the physicochemical and structural properties J. Pharm. Sci. 89 2001 614 626
22. 13C spectroscopy of mono-, di-, tri- and tetrasubstituted xanthones Magn. Reson. Chem. 36 1998 305 309
23. M. Teixeira, M.M.M. Pinto, and C.M. Barbosa Validation of a spectrophotometric method for quantification of xanthone in biodegradable nanoparticles Pharmazie 59 2004 257 259
24. M. Teixeira, C.M.M. Afonso, M.M.M. Pinto, and C.M. Barbosa A validated HPLC method for assay of xanthone and 3-methoxyxanthone in PLGA nanocapsules J. Chromatogr. Sci. 41 2003 371 376
25. M.Y. Levy, and S. Benita Drug release from submicronized O/W emulsion: a new in vitro kinetic evaluation model Int. J. Pharm. 66 1990 29 37
26. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
27. P. Ahlin, J. Kristl, A. Kristl, and F. Vrecer Investigation of polymeric nanoparticles as carriers of enaprilat for oral administration Int. J. Pharm. 239 2002 113 120
28. A.A. Esteller, Sistemas coloidales, in: Fisicoquímica para farmácia y biologia, Ediciones Científicas y Técnicas, Barcelona, Spain. 1992 pp. 925-956.
29. M.D. Blanco, and M.J. Alonso Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres Eur. J. Pharm. Biopharm. 43 1997 287 294
30. T. Govender, S. Stolnik, M.C. Garnett, L. Illum, and S. Davis PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug J. Control Release 57 1999 171 185
31. S.S. Guterres, H. Fessi, G. Barratt, J.-P. Devissaguet, and F. Puisieux Poly(dl-lactide) nanocapsules containing diclofenac: I. Formulation and stability study Int. J. Pharm. 113 1995 57 63
32. M. Fresta, G. Cavallaro, G. Giammona, E. Wehrli, and G. Puglisi Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs Biomaterials 17 1996 751 758
33. V. Ferranti, H. Marchais, C. Chabenat, A.M. Orecchioni, and O. Lafont Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles Int. J. Pharm. 193 1999 107 111
34. P. Calvo, Desarrollo de nuevos sistemas coloidales y su aplicación en la administración tópica y ocular de medicamentos, PhD Thesis, Universidad de Santiago de Compostela, Facultad de Farmacia, Spain (1995) pp.119-160.
35. P. Calvo, J.L. Vila Jato, and M.J. Alonso Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carries J. Pharm. Sci. 85 1996 530 536
36. H. Marchais, S. Benali, J. Irache, C. Thrasse-Bloch, O. Lafont, and A.M. Orecchioni Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters Drug Dev. Ind. Pharm. 24 1998 883 888
37. L. Marchal-Heussler, H. Fessi, M. Devissaguet, M. Hoffman, and P. Maincent Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, polylactic-co-glycolic acid, poly-epsilon-caprolacton STP Pharma Sci. 2 1992 98 104
38. C. Losa, L. Marchal-Heussler, F. Orallo, J.L. Vila Jato, and M.J. Alonso Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol Pharm. Res. 10 1993 80 87
39. N. Ammoury, H. Fessi, J.P. Devissaguet, F. Puisiex, and S. Benita In vitro release kinetic pattern of indomethacin from poly(d,l-Lactide) nanocapsules J. Pharm. Sci. 79 1990 763 767
40. N.S. Santos-Magalhães, A. Pontes, V.M.W. Pereira, and M.N.P. Caetano Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules Int. J. Pharm. 208 2000 71 80
41. C. Morin, G. Barrat, H. Fessi, H. J, P. Devissaguet, and F. Puisieux Improved intracellular delivery of muramyl dipeptide analog by means of nanocapsules Int. J. Immunopharmacol. 16 1994 451 456
42. G. Barrat, F. Puisieux, W.P. YU, C. Foucher, H. Fessi, and J.-P. Devissaguet Anti-metastatic activity of MDP-l-alanyl-cholesterol incorporated into various types of nanocapsules Int. J. Pharm. 16 1998 457 461
43. B. Magenheim, and S. Benita Nanoparticle Characterization: a comprehensive physicochemical approach STP Pharma Sci. 1 1991 221 241
44. R. Bodmeier, and P. Mainceint Polymeric dispersions as drug carriers H.A. Lieberman M.M. Rieger G.S. Banker Pharmaceutical Dosage Forms: Disperse Systems vol. 3 1998 Marcel Dekker New York 87 127
45. S. Schaffazick, A. Pohlmann, L. Freitas, and S. Guterres Caracterização e estudo de estabilidade de suspensões de nanocápsulas e de nanoesferas poliméricas contendo diclofenaco Acta Farm. Bonaerense 21 2002 99 106